Literature DB >> 15135093

Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry.

Therese Koal1, Michael Deters, Bruno Casetta, Volkhard Kaever.   

Abstract

In this study immunosuppressants, i.e. cyclosporin A (CyA), tacrolimus (TRL), sirolimus (SRL) and everolimus (RAD) were quantified in whole blood samples from immunosuppressant treated transplant recipients by an integrated on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry (SPE-HPLC-MS/MS) system. This method has been developed to improve the following characteristics: speed, robust analysis, simultaneous determination and low cost. This can be achieved by the use of a perfusion column as an extraction cartridge in combination with a short HPLC column and highly selective and sensitive atmospheric pressure ionisation tandem mass spectrometry (API-MS/MS) in the multiple reaction monitoring (MRM) detection mode. This high throughput technique is perfectly appropriate for routine therapeutic drug monitoring (TDM) of organ transplanted patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135093     DOI: 10.1016/j.jchromb.2004.02.040

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  10 in total

1.  Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.

Authors:  Eric Dailly; G Deslandes; M Hourmant; T Petit; C Renaud; M Treilhaud; P Jolliet
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors:  Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.

Authors:  Christin C Rogers; Rita R Alloway; J Wesley Alexander; Michael Cardi; Jennifer Trofe; Alexander A Vinks
Journal:  Clin Transplant       Date:  2008 May-Jun       Impact factor: 2.863

4.  Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS.

Authors:  Mustafa Karapirli; Murat Kizilgun; Ozgur Yesilyurt; Husamettin Gul; Zeki Ilker Kunak; Emin Ozgur Akgul; Enis Macit; Tuncer Cayci; Yasemin Gulcan Kurt; Ibrahim Aydin; Hakan Yaren; Melik Seyrek; Erdinc Cakir; Halil Yaman
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content.

Authors:  C Emoto; T Fukuda; S Cox; U Christians; A A Vinks
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-07-24

6.  Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective study.

Authors:  Shinya Takasaki; Hiroaki Yamaguchi; Yoshihide Kawasaki; Masafumi Kikuchi; Masaki Tanaka; Akihiro Ito; Nariyasu Mano
Journal:  J Pharm Health Care Sci       Date:  2019-03-12

7.  Current literature in mass spectrometry.

Authors: 
Journal:  J Mass Spectrom       Date:  2004-11       Impact factor: 1.982

Review 8.  The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.

Authors:  Federica Saponaro; Rebecca Ferrisi; Francesca Gado; Beatrice Polini; Alessandro Saba; Clementina Manera; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

9.  Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate.

Authors:  F S Chung; S Eyal; M Muzi; J M Link; D A Mankoff; A Kaddoumi; F O'Sullivan; P Hsiao; J D Unadkat
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 9.473

10.  Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.

Authors:  C Emoto; T Fukuda; T N Johnson; D M Adams; A A Vinks
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.